Clinical trial
The Impact of Injection of a Loading Dose of Unfractionated Heparin on Patients With Acute ST-segment Elevation Myocardial Infarction Scheduled for Primary PCI at Initial Medical Contact: A Multicenter, Prospective, Randomized Controlled Study(HELP-PCI 2)
NCT07361783 is registered in ClinicalTrials.gov with Chen Jing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Injection of a Loading Dose of Unfractionated Heparin on Patients With Acute ST-segment Elevation Myocardial Infarction Scheduled for Primary PCI at Initial Medical Contact: A Multicenter, Prospective, Randomized Controlled Study(HELP-PCI 2)
- Lead sponsor
- Chen Jing
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 25, 2026
- Completion date
- April 1, 2030
- Enrollment
- 6,294 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary pci, st-elevation myocardial infarction (stemi)